Health ยท Rwanda

African Medicines Agency Opens Two Hubs in Kigali to Support Local Drug Production

The African Medicines Agency has opened two hubs in Kigali to coordinate regulators and manufacturers and harmonise standards. One will serve as an entry point for manufacturers seeking to set up on the continent; the other will focus on training and capacity building for local producers.

The African Medicines Agency (AMA) opened two new hubs in Kigali, Rwanda, on Tuesday 27 October, extending the rollout of the structures of the African Union's newest agency. The hubs are meant to act as coordination platforms for medicines regulators and industry, with the aim of harmonising standards and encouraging local production of medical products.

The step follows the establishment of seven technical committees on Monday 26 October. The agency has been operational since the end of 2025.

According to the details provided, the first hub is intended as a gateway for manufacturers wishing to establish operations on the continent. The second is designed to strengthen capacity and regulation through cooperation and training.

AMA expert Solomon Onen said the second hub would support local production capacity by giving scientific guidance to innovators on the continent, helping them comply with good laboratory practice and assisting them in preparing the application dossiers required to access the African market.

The African Union has set a target of producing at least 60 percent of the continent's medical product needs by 2040. Paul Lavlani, founder of the training centre Empower and a member of an initiative in Nigeria to develop local industries, said the agency could contribute to Africa's health independence. He pointed to the African Continental Free Trade Area as one of the mechanisms already in place and said the AMA aims to introduce a single continent-wide authorisation. He described this as a beginning, arguing that building capacity in all countries at once could ease trade while improving medicine quality.

Before the hubs were inaugurated, the agency had already begun discussions with manufacturers. It had also started jointly drafting a protocol for clinical trials of potential vaccines against the Bundibugyo strain of the Ebola virus.

More reporting from Voice of Africans